HUTCHMED ( $HCM) Climbs +13% on GSK Deal and Pipeline Momentum (See the latest news for any ticker on Tickeron.) HUTCHMED (HCM) shares climbed roughly 13% over the last 30 days, rising from about $12.38 to near $14.01. The rally was driven primarily by a global licensing agreement with GSK announced on September 3, 2026, covering the antibody-targeted therapy conjugate candidate HMPL-A830. $ACET $CGC $GELS $SNDL $RMTI
published
HUTCHMED ( $HCM) Climbs +13% on GSK Deal and Pipeline Momentum (See the latest news for any ticker on Tickeron.) HUTCHMED (HCM) shares climbed roughly 13% over the last 30 days, rising from about $12.38 to near $14.01. The rally was driven primarily by a globa
$HCM$ACET$CGC$GELS$SNDL$RMTI
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.
